Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.galinos.gr › web › drugsΓαληνός - Δραστική ουσία - Μπεμπεδοϊκό οξύ - Γενικά

   www.galinos.gr › web › drugs

   • Αποθηκευμένο αντίγραφο

   Το μπεμπεδοϊκό οξύ είναι ένας αναστολέας της αδενοσινοτριφωσφορικής κιτρικής λυάσης (ACL) που μειώνει τη χοληστερόλη των λιποπρωτεϊνών χαµηλής πυκνότητας (LDL-C) μέσω αναστολής της σύνθεσης της χοληστερόλης στο ήπαρ.

2. en.wikipedia.org › wiki › Bempedoic_acidBempedoic acid - Wikipedia

   en.wikipedia.org › wiki › Bempedoic_acid

   • Αποθηκευμένο αντίγραφο

   Bempedoic acid is a medication for high blood cholesterol levels that blocks an enzyme in the liver. It is approved in the US and the EU, and can be used with or without statins.

3. www.drugs.com › bempedoic-acidBempedoic acid: Uses, Dosage, Side Effects, Warnings - Drugs.com

   www.drugs.com › bempedoic-acid

   • Αποθηκευμένο αντίγραφο

   25 Ιουλ 2024 · Bempedoic acid (Nexletol) is a non-statin cholesterol-lowering medicine that may reduce the risk of heart attack and heart procedures. Learn about its side effects, interactions, cost, and how to take it safely.

4. Κυριότερες Ειδήσεις

   • Yahoo Finance

     Otsuka Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia

     Esperion (NASDAQ: ESPR) today announced that Otsuka Pharmaceutical Co., Ltd. (Otsuka) has submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare for the manufacture and sale of bempedoic acid in Japan for the treatment of hypercholesterolemia and familial hypercholesterolemia.

     24 ώρες Πριν από

   • 

     The Pharma Letter

     Otsuka submits NDA in Japan for bempedoic acid

     6 ημέρες Πριν από

   • Business Insider

     Buy Rating Affirmed for Esperion Due to Bempedoic Acid’s Clinical Efficacy in Recent Trials

     Esperion (ESPR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis from

     2 εβδομάδες Πριν από

   • Business Insider

     Esperion announces Otsuka submitted NDA to Japanese MHLW for bempedoic acid

     Esperion (ESPR) announced that Otsuka Pharmaceutical (OSUKF) has submitted a New Drug Application, NDA, to the Japanese Ministry of Health,

     7 ημέρες Πριν από

   • The Globe and Mail

     Esperion Reports Third Quarter 2024 Financial Results and Provides a Business Update

     In addition, we substantially strengthened our balance sheet by monetizing the European royalties on our bempedoic acid product sales and allocated the proceeds for the early, discounted payoff and termination of a previous revenue interest facility ...

     2 εβδομάδες Πριν από

5. www.acc.org › latest-in-cardiology › articlesBempedoic Acid for LDL-C Lowering: What Do We Know?

   www.acc.org › latest-in-cardiology › articles

   • Αποθηκευμένο αντίγραφο

   10 Αυγ 2020 · Bempedoic acid is a new class of nonstatin LDL-lowering therapy that, like statins, targets the cholesterol biosynthesis pathway in the liver. 3 Whereas statins inhibit HMG CoA reductase, bempedoic acid inhibits ATP-citrate lyase (ACL), two steps upstream of HMG CoA reductase. 3 Unlike statins, bempedoic acid is administered as a prodrug and is ...

6. www.drugs.com › tips › bempedoic-acid-patient-tipsBempedoic acid: 7 things you should know - Drugs.com

   www.drugs.com › tips › bempedoic-acid-patient-tips

   • Αποθηκευμένο αντίγραφο

   26 Σεπ 2023 · Bempedoic acid is a prescription medicine that lowers LDL-C (bad cholesterol) in adults with high cholesterol or heart disease. It works by blocking an enzyme in the liver and is used with other lipid-lowering medicines, but not with statins.

7. www.ncbi.nlm.nih.gov › books › NBK594232Bempedoic Acid - StatPearls - NCBI Bookshelf

   www.ncbi.nlm.nih.gov › books › NBK594232

   28 Φεβ 2024 · Bempedoic acid is a lipid-lowering agent pivotal in managing patients with elevated low-density lipoprotein cholesterol (LDL-C) levels.

8. www.mayoclinic.org › drugs-supplements › bempedoic-acid-oral-routeBempedoic acid (oral route) - Mayo Clinic

   www.mayoclinic.org › drugs-supplements › bempedoic-acid-oral-route

   • Αποθηκευμένο αντίγραφο

   1 Φεβ 2024 · Bempedoic acid is used together with diet and other cholesterol-lowering medicines to reduce bad cholesterol (LDL) in patients with primary hyperlipidemia (high blood cholesterol), including heterozygous familial hypercholesterolemia (HeFH).